EverQuote (NASDAQ:EVER) Stock, Quote.Headers.trade-ideas

EverQuote

EverBank Financial

EverBank Financial Corp.

NYSE

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Le ultime operazioni degli insider: cosa sta succedendo sui mercati?

News

Price Target

Markets

Analyst Ratings

Trading Ideas

AXSM

CRWD

EBAY

EVER

FRPT

PLTR

RXST

Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday

Earnings

Earnings Beats

Small Cap

ROOT

MetLife, Inc.&#39;s (NYSE: MET) institutional asset management arm, MetLife Investment Management (&#34;MIM&#34;), recently launched its second private equity fund, MetLife Investment Private Equity Partners II, securing around $1.2 billion in commitments.

MetLife Arm MIM Secures $1.2B for 2nd Private Equity Fund

LMND

Old Republic International Corporation&#39;s (NYSE: ORI) solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and strong capital position make it worth adding to one&#39;s portfolio.

Should You Add Old Republic Stock for Better Returns?

EverQuote Inc

Everscale

EVERBRIDGE INC COM

EVERBRIDGE ORD

EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD

EVEREST GROUP ORD

EVERGREEN MARINE CORP by Evergreen Marine Corp. Ltd.

EVERGREEN PRODS GROUP LTD by EVERGREEN PRODS GROUP LTD.

EVERSOURCE ENERGY ORD

EVERSPIN TECHNOLOGIE ORD

EVER HARVEST INTL GRP by Ever Harvest International Group Inc.

Ever Harvest International Group Inc

EVER-GLORY INTL GROUP INC by Ever-Glory International Group, Inc.

Ever-Glory International Group Inc

EverCommerce Inc

EVERGEN INFRASTRUCTURE CP by EverGen Infrastructure Corp.

EverGen Infrastructure Corp

EverRise

Evercel Inc

Evercore Inc

Everdime Inc

Everest

Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50

Everest Consolidator Acquisition Corp

Everest Consolidator Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant

Everest Consolidator Acquisition Corporation Class A Common Stock

Everest Group Ltd

EVEREST METALS CORP LTD by EVEREST METALS CORP LTD.

Everest Metals Corp Ltd

Evergold Corp

EVERGRANDE PPTY SVC GRP by Evergrande Property Services Group Limited

Evergrande Property Services Group Ltd

EVERGRANDE PPTY UNSP/ADR by Evergrande Property Services Group Limited

Evergreen Corp

Evergreen Corporation - Class A Ordinary Share

EVERGREEN PRODS GROUP ADR by Evergreen Products Group Ltd

Evergreen Products Group Ltd

EVERGREEN SUSTAIN ENTPRS by Evergreen Sustainable Enterprises Inc.

Evergreen Sustainable Enterprises Inc

Evergy Inc

Everi Holdings Inc

Everipedia

Everlert Inc

Everock Inc

Eversource Energy

Everspin Technologies, Inc. - Common Stock

Everspin Technologies Inc

Evertec Inc

EVERTZ TECHNOLOGIES LTD by Evertz Technologies Ltd.

Evertz Technologies Ltd

EVERYBODY LOVES LANGUAGES by EVERYBODY LOVES LANGUAGES CORP.

Everybody Loves Languages Corp

EVERYDAY PEOPLE FINL CORP by Everyday People Financial Corp.

Everyday People Financial Corp

EVERYTHING BLOCKCHAIN INC by EVERYTHING BLOCKCHAIN INC.

Everything Blockchain Inc

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and raises the price target from $29 to $34.

JP Morgan Maintains Overweight on EverQuote, Raises Price Target to $34

Craig-Hallum analyst Jason Kreyer maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $30 to $33.

Craig-Hallum Maintains Buy on EverQuote, Raises Price Target to $33

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler cut the price target for CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from $310 to $290. Piper Sandler analyst Rob Owens upgraded the stock from Neutral to Overweight. CrowdStrike shares gained 1.9% to close at $222.05 on Monday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank raised the price target for Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) from $20 to $21. Deutsche Bank analyst Brad Zelnick maintained the stock with a Sell rating. Palantir shares fell 2.6% to close at $24.09 on Monday. <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut RxSight, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) price target from $75 to $54. Needham analyst David Saxon maintained a Buy rating. RxSight shares fell 2.4% to close at $40.78 on Monday. <a href="https://www.benzinga.com/quote/RXST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised the price target for Axsome Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) from $95 to $106. B of A Securities analyst Jason Gerberry upgraded the stock from Neutral to Buy. Axsome Therapeutics shares fell 1.4% to close at $83.21 on Monday. <a href="https://www.benzinga.com/quote/AXSM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) price target from $135 to $140. Baird analyst Peter Benedict maintained an Outperform rating. Freshpet shares fell 0.6% to close at $121.41 on Monday. <a href="https://www.benzinga.com/quote/FRPT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised Lithia Motors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) price target from $280 to $315. JP Morgan analyst Rajat Gupta maintained an Overweight rating. Lithia Motors shares fell 4.6% to close at $276.76 on Monday. <a href="https://www.benzinga.com/quote/LAD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham raised the price target for EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) from $30 to $38. Needham analyst Mayank Tandon maintained a Buy rating. EverQuote shares fell 3.5% to close at $23.96 on Monday. <a href="https://www.benzinga.com/quote/EVER/analyst-ratings">See how other analysts view this stock.</a></li>
<li>BMO Capital boosted Tyson Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) price target from $58 to $60. BMO Capital analyst Andrew Strelzik maintained a Market Perform rating. Tyson shares rose 2.1% to close at $62.51 on Monday. <a href="https://www.benzinga.com/quote/TSN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities raised eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) price target from $50 to $58. Truist Securities analyst Youssef Squali maintained a Hold rating. EVgo shares fell 2.7% to close at $54.66 on Monday. <a href="https://www.benzinga.com/quote/EBAY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) price target from $155 to $160. JP Morgan analyst Rajat Gupta maintained a Neutral rating. AutoNation shares dipped 2.7% to close at $166.06 on Monday. <a href="https://www.benzinga.com/quote/AN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40178833/dow-records-worst-day-in-around-2-years-mag-7-stocks-lose-650b-in-market-capitalization-greed-index">Dow Records Worst Day In Around 2 Years, Mag 7 Stocks Lose $650B In Market Capitalization: Greed Index Moves To &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

WIIM

EverQuote shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $30 to $38.

Needham analyst Mayank Tandon maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $30 to $38.

Needham Maintains Buy on EverQuote, Raises Price Target to $38

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.03 by 466.67 percent. This is a 160.71 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $117.14 million which beat the analyst consensus estimate of $102.81 million by 13.94 percent. This is a 72.30 percent increase over sales of $67.98 million the same period last year.

EverQuote Q2 EPS $0.17 Beats $0.03 Estimate, Sales $117.14M Beat $102.81M Estimate

Third Quarter&nbsp;2024&nbsp;Outlook:
<ul>
<li>Variable Marketing Margin of&nbsp;$38.5&nbsp;-&nbsp;$41.5 million.</li>
<li>Adjusted EBITDA of&nbsp;$14.0&nbsp;-&nbsp;$17.0 million.</li>
</ul>

Guidance

EverQuote Expects Q3 Revenue Of $137M - $143M, Est $98.85M

EverQuote shares are trading higher. The company reported Q2 financial results.

MetLife, Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/met#NYSE">MET</a>) institutional asset management arm, MetLife Investment Management (&quot;MIM&quot;), recently launched its second private equity fund, MetLife Investment Private Equity Partners II, securing around $1.2 billion in commitments. This new fund, aimed at institutional clients, includes a portfolio of about $860 million in private equity and co-investment interests. Combined with funded and unfunded commitments, the total reaches $975 million.
The transaction was anchored by Lexington Partners L.P., the lead investor in the project. MIM also plans to utilize $250 million on new private equity opportunities. The successful closing of this fund highlights MIM&#39;s expanding capabilities and leadership in private markets. This strategic move follows the strong performance of MetLife&#39;s private equity investments, which, at first quarter-end, held $14.3 billion in assets.
The private equity team of MIM alone has invested more than $20 billion in alternative investments in the 2010-2023 period. The deal was advised by Evercore, and it further underscores MIM&#39;s commitment to offer tailored investment solutions to institutional investors around the globe. It had $593.7 billion in assets under management as of the first quarter-end.
This move will likely expand MIM&#39;s private equity platform and attract more institutional investors, boosting MetLife&#39;s assets under management and overall financial growth. The overall resilience of the economy offers a stable backdrop for launching new investment vehicles.
Investors are seeking diversification and strong returns in private equity, maintaining high demand for such investments among institutional investors. Given the strong long-term performance of MIM&#39;s private equity investments, this seems like an opportune moment to leverage its track record.
<h3>Price Performance</h3>
MetLife&#39;s shares have gained 20.9% in the past year compared with the 21.6% growth of the industry it belongs to.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/73/70804.jpg?v=1840979077" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
MetLife currently has a Zacks Rank #3 (Hold).
Investors interested in the broader&nbsp;Finance&nbsp;space may look at some better-ranked players like Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>), Brown &amp; Brown, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>). While Root currently sports a Zacks Rank #1 (Strong Buy), Brown &amp; Brown and EverQuote carry a Zacks Rank #2 (Buy) each.
The consensus mark for ROOT&#39;s current-year earnings indicates a 60.6% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 34.1%. Furthermore, the consensus estimate for Root&#39;s 2024 revenues suggests 125.3% year-over-year growth.
The Zacks Consensus Estimate for Brown &amp; Brown&#39;s current-year earnings is pegged at $3.61 per share, which indicates 28.5% year-over-year growth. It has witnessed one upward estimate revision against none in the opposite direction during the past 60 days. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 11.9%.
The consensus mark for EverQuote&#39;s current-year earnings indicates a 103.3% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 65.2%. Furthermore, the consensus estimate for EVER&#39;s 2024 revenues suggests 33.9% year-over-year growth.
<a href="https://www.zacks.com/stock/news/2298720/metlife-met-arm-mim-secures-1-2b-for-2nd-private-equity-fund?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2298720">To read this article on Zacks.com click here.</a>

Old Republic International Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>) solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and strong capital position make it worth adding to one&#39;s portfolio.
<h3>Optimistic Growth Projections</h3>
The Zacks Consensus Estimate for Old Republic&#39;s 2024 earnings per share indicates a year-over-year increase of 3.8%. The consensus estimate for revenues is pegged at $7.96 billion, implying a year-over-year improvement of 6.8%. 
The consensus estimate for 2025 earnings per share and revenues indicates an increase of 4.4% and 4%, respectively, from the corresponding 2024 estimates. 
Earnings have grown 10.3% in the past five years, better than the industry average of 9.2%
<h3>Earnings Surprise History</h3>
Old Republic has a solid record of beating earnings estimates in three of the last four quarters while missing in one, the average being 6.61%.
<h3>Zacks Rank &amp; Price Performance</h3>
ORI currently carries a Zacks Rank #2 (Buy). In the past year, the stock has gained 23.1%, outperforming the industry&#39;s growth of 19.6%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/e9/68556.jpg?v=830495571" /> 
Image Source: Zacks Investment Research
<h3>Style Score</h3>
Old Republic has a VGM Score of B. The VGM Score helps identify stocks with the most attractive value, best growth and the most promising momentum. 
Back-tested results have shown that stocks with a VGM Score of A or B combined with a Zacks Rank #1 (Strong Buy) or 2 offer better returns.
<h3>Attractive Valuation</h3>
ORI shares are trading at a price-to-book multiple of 1.30, lower than the industry average of 2.53. The company has a Value Score of B. This style score helps find the most attractive value stocks.
<h3>Business Tailwinds</h3>
ORI&#39;s General Insurance segment should continue to benefit from segmentation, better risk selection, meticulous pricing and increased use of analytics. This, in turn, has helped deliver a combined ratio below 96 for 14 years. The insurer aims combined ratio between 90 and 95. 
The Title business, on the other hand, should continue to benefit from an expanding presence in the commercial real estate market. 
Banking on operational strength, this third-largest title insurer in the country distributes wealth to its shareholders in the form of dividends and share repurchases. ORI has an impressive dividend history banking on operational excellence. It has increased dividends for 43 straight years. It has been paying dividends for the last 83 years, besides paying special dividends occasionally, making it an attractive pick for yield-seeking investors. Its board recently approved a $1.1 billion share buyback program. 
Old Republic International is one of the 111 companies that have posted at least 28 consecutive years of annual dividend growth. The insurer has returned 12.6% per share for the last 10 years to shareholders. 
Return on invested capital in the trailing 12 months was 5.9%, better than the industry average of 2%, reflecting ORI&#39;s efficiency in utilizing funds to generate income.
<h3>Other Stocks to Consider</h3>
Some other top-ranked stocks from the multi-line insurance industry are Lemonade, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>), EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) and Radian Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rdn#NYSE">RDN</a>), each carrying a Zacks Rank #2 at present. 
Lemonade has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 12.82%. Shares of LMND have plunged 22.2% in the past year. 
The Zacks Consensus Estimate for LMND&#39;s 2024 and 2025 earnings implies year-over-year growth of 13.5% and 18.3%, respectively. 
EverQuote&#39;s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 65.16%. Shares of EVER have skyrocketed 171.8% in the past year. 
The Zacks Consensus Estimate for EverQuote&#39;s 2024 and 2025 earnings per share indicates a year-over-year increase of 102.6% and 362.50%, respectively. 
Radian has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 22.79%. Shares of RDN have climbed 17% in the past year. 
The Zacks Consensus Estimate for RDN&#39;s 2024 and 2025 revenues implies year-over-year growth of 8.2% and 4.9%, respectively.
<a href="https://www.zacks.com/stock/news/2286581/should-you-add-old-republic-ori-stock-for-better-returns?cid=CS-BENZ-FT-analyst_blog|rank_focused-2286581">To read this article on Zacks.com click here.</a>

EverQuote (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) delivered first-quarter 2024 earnings per share of 5 cents in contrast to the Zacks Consensus Estimate of a loss of 7 cents as well as the year-ago quarter&#39;s loss of 8 cents per share. 
Though the top line of $91 million declined 16.5% year over year, it beat the Zacks Consensus Estimate by 12.8%. 
Both the metrics exceeded expectations, likely reflecting the early stages of auto carrier recovery.
<h3>EverQuote, Inc. Price, Consensus and EPS Surprise <a href="https://www.zacks.com/stock/chart/EVER/price-consensus-eps-surprise-chart?icid=chart-EVER-price-consensus-eps-surprise-chart"> </a></h3>
&nbsp;
<div class="chart_embed">
<h3><a href="https://www.zacks.com/stock/chart/EVER/price-consensus-eps-surprise-chart?icid=chart-EVER-price-consensus-eps-surprise-chart"><img alt="EverQuote, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/d1/1715092618.png" style="height:265px; width:578px" title="" /> </a></h3>
EverQuote, Inc. price-consensus-eps-surprise-chart | EverQuote, Inc. Quote
</div>
<h3>Behind the Headlines</h3>
Revenues from the Automotive insurance vertical were $77.5 million, down 13.6% year over year. The Zacks Consensus Estimate was pegged at $67 million. Our estimate was $64.6 million. 
Revenues in the Home and Renters insurance vertical totaled $12.7 million, which increased 34.2% year over year. The Zacks Consensus Estimate was pegged at $13.3 million. Our estimate was $15.3 million. 
Revenues in the Other insurance vertical totaled $0.1 million, which plunged 16.3% year over year. 
Total costs and operating expenses decreased 20% to $89.3 million, mainly due to the cost of&nbsp; revenues and lower sales and marketing, general and administrative and research and development expenses. Our estimate was $77.5 million. 
EverQuote&#39;s variable marketing margin decreased 13.4% year over year in the quarter under review to $30.8 million. Our estimate was $27.6 million, while the Zacks Consensus Estimate was pegged at $26.4 million. 
Adjusted EBITDA was $7.6 million, up 41.2% year over year. Our estimate was $4.5 million.
<h3>Financial Update</h3>
EverQuote exited the first quarter of 2024 with cash and cash equivalents of $48.6 million, up 28% from 2023-end. Total assets were $135.4 million, up 22.1% from 2022-end. Total stockholders&#39; equity increased 9.2% to $88.3 million. 
Cash from operations was $10.4 million in the reported quarter versus an outflow of $1.2 million in the year-ago quarter.
<h3>Q2 Guidance</h3>
EverQuote estimates revenues in the range of $100-$105 million, a variable marketing margin of $31-$33 million and adjusted EBITDA in the range of $7 million-$9 million.
<h3>Zacks Rank</h3>
EVER currently carries a Zacks Rank #2 (Buy).
<h3>Performance of Other Insurers</h3>
MGIC Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtg#NYSE">MTG</a>) reported first-quarter 2024 operating net income per share of 65 cents, which beat the Zacks Consensus Estimate by 8.3%. The better-than-expected earnings were driven by higher net investment income and lower underwriting and other expenses. The insurer continues to benefit from favorable credit trends and the resiliency of the housing market.&nbsp; The bottom line improved 20.3% year over year. 
MGIC Investment recorded total operating revenues of $303 million, which increased 3.8% year over year on higher net investment income. The top line, however, missed the consensus mark by 0.4%. 
Insurance in force declined 0.5% from the prior-year quarter to $290.9 billion. The company missed our estimate of $292.6 billion. The insurer witnessed a 2.5% decrease in primary delinquency to 24,142 loans. New insurance written was $9.1 billion, up 11% year over year, benefiting from favorable credit trends and the resiliency of the housing market. 
Radian Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rdn#NYSE">RDN</a>) reported first-quarter 2024 adjusted operating income of $1.03 per share, which beat the Zacks Consensus Estimate by 24%. The bottom line increased 5.1% year over year. The results reflected improved persistency and a rise in premiums and insurance written, partially offset by higher expenses. 
Operating revenues rose 4.8% year over year to $318.9 million, primarily due to higher net premiums earned, services revenues and net investment income. 
MI New Insurance Written rose 2.4% year over year to $11.5 billion. Primary mortgage insurance in force was $271 billion as of Mar 31, 2024, up 4% year over year. The expense ratio was 25, which improved 90 bps from the year-ago quarter. 
Everest Group, Ltd.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eg#NYSE">EG</a>) first-quarter 2024 operating income of $16.32 per share beat the Zacks Consensus Estimate by 2.1%. The bottom line jumped 44.3% year over year. Everest Group&#39;s total operating revenues of $4.14 billion climbed 26% year over year on higher premiums earned and net investment income. The top line missed the consensus mark by 1.4%. 
Pre-tax underwriting income was $409 million, which soared 50% year over year. Pre-tax catastrophe losses net of estimated recoveries and reinstatement premiums were $85 million, narrower than the loss of $110 million in the year-ago quarter. The loss was due to the Francis Scott Key Bridge Collapse in Baltimore. The combined ratio improved 240 basis points year over year to 88.8 in the reported quarter. The figure matched the Zacks Consensus Estimate, while our estimate was 85.5.
<a href="https://www.zacks.com/stock/news/2269879/everquote-ever-q1-earnings-top-estimates-revenues-fall-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2269879">To read this article on Zacks.com click here.</a>

EverQuote Q1 Earnings Top Estimates, Revenues Fall Y/Y

Shares of Beyond, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) fell sharply during Tuesday&#8217;s session following weaker-than-expected <a href="https://www.benzinga.com/quote/BYON">quarterly results</a>.
Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. The company&#8217;s sales came in at $382.281 million versus estimates of $389.264 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Beyond shares dipped 20.8% to $17.34 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Golden Sun Health Technology Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) shares gained 94.7% to $5.60. Golden Sun Health Technology Group regained compliance with Nasdaq continued listing requirement.</li>
<li>MMTec, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) gained 79.1% to $4.1189.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares climbed 50.5% to $0.2572 after the company posted a narrower-than-expected quarterly loss.</li>
<li>Great Lakes Dredge &amp; Dock Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLDD#NASDAQ">GLDD</a>) rose 31.5% to $9.26 following better-than-expected first-quarter financial results.</li>
<li>American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) jumped 29.6% to $7.52.</li>
<li>Motorsport Games Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) gained 29.2% to $2.9493. Motorsport Games is expected to report its financial results for the first quarter of 2024 on Tuesday, May 7.</li>
<li>FibroGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) surged 28.7% to $1.4899 after the company reported mixed first quarter financial results.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) rose 26.7% to $5.07 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) gained 25.1% to $1.0699 after the company announced the completion of its previously announced acquisition of Naamche.</li>
<li>Dave Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NYSE">DAVE</a>) gained 25% to $58.20 after the company reported better-than-expected first-quarter financial results and issued FY24 operating revenue.</li>
<li>Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) surged 24.8% to $1.46 after the company signed an exclusive patent licensing agreement with Yissum Research Development Company.</li>
<li>Thoughtworks Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWKS#NASDAQ">TWKS</a>) jumped 22% to $3.0750 after the company issued strong guidance.</li>
<li>The Real Brokerage Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) gained 21.5% to $5.07 following strong quarterly sales.</li>
<li>Global Self Storage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SELF#NASDAQ">SELF</a>) rose 21.2% to $5.05.</li>
<li>Zeta Global Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NASDAQ">ZETA</a>) rose 21% to $15.72 after the company reported better-than-expected first-quarter financial results and increased its second-quarter revenue guidance.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) climbed 19.3% to $6.53 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Bandwidth Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAND#NASDAQ">BAND</a>) gained 19.2% to $24.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>ADTRAN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) climbed 18.4% to $5.58 following upbeat quarterly results.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) gained 18.3% to $6.47 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Ambac Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBC#NYSE">AMBC</a>) shares rose 16.5% to $17.64 following better-than-expected first-quarter earnings.</li>
<li>FibroGen, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) gained 15.5% to $1.34 after the company reported mixed first-quarter financial results.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) rose 15.1% to $121.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>Coca-Cola Consolidated, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) jumped 14.5% to $981.96 following first-quarter results.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) gained 14% to $215.29 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance above estimates.</li>
<li>J&amp;J Snack Foods Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) gained 13.5% to $156.51 following better-than-expected quarterly results.</li>
<li>Artivion, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) gained 13.4% to $23.90 following strong quarterly results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) gained 12.7% to $24.09 after the company reported better-than-expected first quarter financial results and issued second quarter revenue guidance above estimates.</li>
<li>Air Transport Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATSG#NASDAQ">ATSG</a>) rose 12.7% to $14.94 following upbeat earnings.</li>
<li>Surgery Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) gained 9.3% to $27.98 following upbeat earnings.</li>
<li>Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) climbed 8.6% to $137.52 following first quarter financial results.</li>
<li>Symbotic Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NYSE">SYM</a>) shares rose 8.1% to $45.33 after the company reported mixed second-quarter financial results.</li>
<li>UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) shares gained 8% to $29.81 after the company posted better-than-expected results for its first quarter.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares gained 6.9% to $12.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Holdco Nuvo Group D.G Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVO#NASDAQ">NUVO</a>) fell 39.2% to $3.1999 after jumping 157% on Monday.</li>
<li>The Real Good Food Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGF#NASDAQ">RGF</a>) dipped 32.6% to $0.5312.</li>
<li>Neuronetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) fell 32.5% to $2.5281 following quarterly results.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRI#NASDAQ">AGRI</a>) shares fell 27.4% to $0.1048 after the company announced an offering of 432.5 million shares by selling stockholders.</li>
<li>Strong Global Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGE#NYSE">SGE</a>) fell 27.4% to $1.9201. Fundamental Global announced acquisition of Strong/MDI Screen Systems, Inc. by FG Acquisition Corp. at a $30 million valuation.</li>
<li>GreenPower Motor Company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GP#NASDAQ">GP</a>) shares declined 25.6% to $1.35 after the company reported pricing of $2.3 million underwritten public offering.</li>
<li>JELD-WEN Holding, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) fell 23.5% to $14.56 as the company posted downbeat quarterly sales and lowered 2024 revenue guidance.</li>
<li>Oriental Culture Holding LTD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) dipped 22.6% to $1.2001.</li>
<li>BT Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBD#NASDAQ">BTBD</a>) fell 21.4% to $1.25.</li>
<li>Plutonian Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTN#NASDAQ">PLTN</a>) shares fell 19.3% to $11.41 after surging 57% on Monday.</li>
<li>Talkspace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>) fell 18.3% to $2.60 following first-quarter results.</li>
<li>Helius Medical Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares declined 16.2% to $2.03 after the company announced pricing of $6.4 million public offering.</li>
<li>Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) fell 15.5% to $18.76 following first-quarter results.</li>
<li>Myers Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) declined 15.5% to $19.43 following first-quarter results.</li>
<li>Builders FirstSource, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) dipped 15.4% to $170.00 following first-quarter earnings.</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) fell 14.3% to $21.56 following soft revenue guidance.</li>
<li>AudioCodes Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUDC#NASDAQ">AUDC</a>) shares fell 13% to $9.89 after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/AUDC/earnings">first-quarter financial results</a></li>
<li>First Watch Restaurant Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) dipped 12.6% to $21.96 following weak quarterly sales.</li>
<li>Teradata Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) dipped 11.4% to $33.63 after the company reported mixed first-quarter financial results and issued second-quarter guidance.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shares fell 11.2% to $2.71 after the company reported mixed first-quarter financial results.</li>
<li>The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) dipped 9.6% to $105.28 following a second-quarter revenue miss.</li>
<li>Methode Electronics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) fell 9.4% to $11.37. Methode Electronics named Kevin Nystrom as interim CEO, effective immediately.</li>
<li>Datadog, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) fell 8.9% to $115.57 following first-quarter results.</li>
<li>Air Lease Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) dipped 7.8% to $47.49 following weak quarterly sales.</li>
<li>Perrigo Company plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) fell 6.3% to $31.32 following weak quarterly sales.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38670858/dow-surges-over-50-points-disney-earnings-top-views">Dow Surges Over 50 Points; Disney Earnings Top Views</a>

Intraday Update

Movers

ADTN

AGRI

AIRE

AMBC

AORT

ATSG

AUDC

BAND

BLDR

BTBD

BYON

CMND

COKE

CROX

DAVE

DDOG

FGEN

FWRG

GLDD

GSUN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSDT

JELD

JJSF

JMIA

LCID

MSGM

NUVO

NUWE

PLTN

PRGO

REAX

SELF

SGRY

STIM

STRL

TALK

TWKS

ZETA

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

B. Riley Securities analyst Daniel Day maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $24 to $29.5.

B. Riley Securities Maintains Buy on EverQuote, Raises Price Target to $29.5

Craig-Hallum analyst Jason Kreyer maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $26 to $30.

Craig-Hallum Maintains Buy on EverQuote, Raises Price Target to $30

EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) reported better-than-expected first-quarter financial results and issued second-quarter revenue <a href="https://www.benzinga.com/quote/EVER">guidance above estimates</a> on Monday.
EverQuote posted quarterly earnings of 5 cents per share, compared to market expectations for a loss of 7 cents per share. The company's quarterly sales came in at $91.06 million versus estimates of $80.31 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
&#8220;We had a strong start to 2024, delivering first quarter results that exceeded the high end of our guidance range for revenue, Variable Marketing Margin, or VMM, and Adjusted EBITDA,&#8221; said Jayme Mendal, CEO of EverQuote. &#8220;We believe we are in the early stages of what will be a multi-year auto carrier recovery as insurers have continued to selectively reactivate marketing campaigns, increase budgets, and expand their state footprints in our marketplace.&nbsp; I want to thank the EverQuote team for the incredible tenacity they have demonstrated and continue to demonstrate through the recent hard market cycle and our customers for their continued partnership.&#8221;
EverQuote said it sees second-quarter revenue of $100 million to $105 million, versus estimates of $77.29 million.
EverQuote shares gained 14.7% to trade at $24.50 on Tuesday.
These analysts made changes to their price targets on EverQuote following earnings announcement.
<ul>
<li>Needham raised the price target on EverQuote from $25 to $30. Needham analyst Mayank Tandon maintained a Buy rating.</li>
<li>Canaccord Genuity boosted the price target on EverQuote from $25 to $30. Canaccord Genuity analyst Michael Graham maintained a Buy rating.</li>
</ul>
Read More: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38670336/bitcoin-falls-below-64-000-starknet-bittensor-among-top-losers">Bitcoin Falls Below $64,000; Starknet, Bittensor Among Top Losers</a>

EverQuote Analysts Boost Their Forecasts After Strong Results

U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday.
Shares of Tempur Sealy International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPX#NYSE">TPX</a>) rose sharply during Tuesday's session <a href="https://www.benzinga.com/quote/TPX/earnings">following upbeat quarterly earnings</a>.
Tempur Sealy reported a first-quarter FY24 sales decline of 1.5% year-on-year to $1.189 billion, missing the analyst consensus estimate of $1.213 billion. Adjusted EPS of 50 cents beat the analyst consensus of 48 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Tempur Sealy International shares gained 6.6% to $53.48 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Great Lakes Dredge &amp; Dock Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLDD#NASDAQ">GLDD</a>) shares jumped 31.5% to $9.26 following better-than-expected first-quarter financial results.</li>
<li>Dave Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NYSE">DAVE</a>) rose 25% to $58.20 after the company reported better-than-expected first-quarter financial results and issued FY24 operating revenue.</li>
<li>Thoughtworks Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWKS#NASDAQ">TWKS</a>) climbed 22% to $3.0750 after the company issued strong guidance.</li>
<li>The Real Brokerage Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) rose 21.5% to $5.07 following strong quarterly sales.</li>
<li>Zeta Global Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NASDAQ">ZETA</a>) shares surged 21% to $15.72 after the company reported better-than-expected first-quarter financial results and increased its second-quarter revenue guidance.</li>
<li>Bandwidth Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAND#NASDAQ">BAND</a>) rose 19.2% to $24.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>ADTRAN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) rose 18.4% to $5.58 following upbeat quarterly results.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) climbed 18.3% to $6.47 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Ambac Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBC#NYSE">AMBC</a>) shares rose 16.5% to $17.64 following better-than-expected first-quarter earnings.</li>
<li>FibroGen, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) climbed 15.5% to $1.34 after the company reported mixed first-quarter financial results.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) gained 15.1% to $121.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>Coca-Cola Consolidated, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) rose 14.5% to $981.96 following first-quarter results.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) jumped 14% to $215.29 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance above estimates.</li>
<li>J&amp;J Snack Foods Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) rose 13.5% to $156.51 following better-than-expected quarterly results.</li>
<li>Artivion, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) rose 13.4% to $23.90 following strong quarterly results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) surged 12.7% to $24.09 after the company reported better-than-expected first quarter financial results and issued second quarter revenue guidance above estimates.</li>
<li>Air Transport Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATSG#NASDAQ">ATSG</a>) jumped 12.7% to $14.94 following upbeat earnings.</li>
<li>Surgery Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) rose 9.3% to $27.98 following upbeat earnings.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) climbed 9.3% to $8.54.</li>
<li>Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) rose 8.6% to $137.52 following first quarter financial results.</li>
<li>Symbotic Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NYSE">SYM</a>) shares gained 8.1% to $45.33 after the company reported mixed second-quarter financial results.</li>
<li>Mueller Water Products, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MWA#NYSE">MWA</a>) rose 8.3% to $17.92 after the company reported better-than-expected seconc-quarter financial results and announced that Marietta Edmunds Zakas has been appointed Chief Executive Officer.</li>
<li>UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) shares rose 8% to $29.81 after the company posted better-than-expected results for its first quarter.</li>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) gained 7% to $4.7550. Citigroup analyst Yigal Nochomovitz initiated coverage on Summit Therapeutics with a Buy rating and announced a price target of $7.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares rose 6.9% to $12.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Otter Tail Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTTR#NASDAQ">OTTR</a>) jumped 5.9% to $96.00 following first-quarter earnings.</li>
<li>Fidelity National Information Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) gained 5.3% to $74.17 as the company reported better-than-expected first-quarter financial results and announced a $500 million increase to 2024 share repurchase goal.</li>
<li>NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) gained 5.1% to $81.86 following upbeat earnings.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38667879/jim-cramer-calls-nutanix-the-perfect-enterprise-software-company-for-the-moment">Jim Cramer Calls Nutanix &#8216;The Perfect Enterprise Software Company For The Moment&#8217;</a>

IBRX

OTTR

SMMT

Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday

Canaccord Genuity analyst Michael Graham maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $25 to $30.

Canaccord Genuity Maintains Buy on EverQuote, Raises Price Target to $30

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for EverQuote, presenting an average target of $25.8, a high estimate of $30.00, and a low estimate of $24.00. This current average has increased by 45.35% from the previous average price target of $17.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1715086820_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive EverQuote. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$30.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Daniel Day</td>
<td>B. Riley Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Cory Carpenter</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$25.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Daniel Day</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$25.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to EverQuote. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of EverQuote compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for EverQuote's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into EverQuote's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EVER/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on EverQuote analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know EverQuote Better</h2>
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
<h3>Breaking Down EverQuote's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Decline in Revenue: Over the 3 months period, EverQuote faced challenges, resulting in a decline of approximately -36.92% in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -11.4%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): EverQuote's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -7.8% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): EverQuote's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -5.64% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: EverQuote's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.03.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Peeling Back The Layers: Exploring EverQuote Through Analyst Insights

Needham analyst Mayank Tandon maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $25 to $30.

Needham Maintains Buy on EverQuote, Raises Price Target to $30

EverQuote shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates.

EverQuote (EVER) has shared an announcement. Everquote has updated its investors with a new presentation available on their website, providing insi...

EverQuote Releases Investor Presentation with Strategic Insights

EverQuote GAAP EPS of $0.17 beats by $0.13, revenue of $117.1M beats by $14.29M

EverQuote, Inc. 2024 Q2 - Results - Earnings Call Presentation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
EverQuote (NASDAQ:<a href="https://investorplace.com/stock-quotes/ever-stock-quote/">EVER</a>) just reported results for the second quarter of 2024.<ul><li>EverQuote reported earnings per share of 17 cents. This was above the analyst estimate for EPS of 3 cents.</li><li>The company reported revenue of $117.14 million.</li><li>This was 13.94% better than the analyst estimate for revenue of $102.81 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ever-stock-earnings-everquote-for-q2-of-2024/">EVER Stock Earnings: EverQuote Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

EVER Stock Earnings: EverQuote Beats EPS, Beats Revenue for Q2 2024

EverQuote, Inc. (EVER) Q2 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Alphabet Class A (GOOGL – Research Repor...

Analysts' Top Communication Services Picks: Alphabet Class A (GOOGL), EverQuote (EVER)

Analysts have been eager to weigh in on the Communication Services sector with new ratings on EverQuote (EVER – Research Report), DoorDash (DASH – ...

Analysts Offer Insights on Communication Services Companies: EverQuote (EVER), DoorDash (DASH) and Take-Two (TTWO)

Oppenheimer analyst Jed Kelly maintained a Hold rating on EverQuote (EVER – Research Report) today. The company's shares closed yesterday at $23.96...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

EverQuote

EverQuote (EVER) Forecast

EverQuote (NASDAQ:EVER) Stock, Quote.Headers.trade-ideas